Medikament

Pharma Giants Boehringer Ingelheim and Eli Lilly Halt Major Investments in Germany

by

The German pharmaceutical landscape is currently navigating a period of significant strategic recalibration as major industry players re-evaluate their domestic capital expenditure plans. Boehringer Ingelheim, one of Germany’s most prominent family-owned pharmaceutical companies, has recently confirmed a shift in its investment strategy, citing concerns over the evolving regulatory and economic environment. This development, occurring alongside … Read more

France to Cover Weight-Loss Injection Costs: The Rules

by

France is set to become the first European Union nation to provide reimbursement for anti-obesity medications, marking a significant shift in how the country approaches the management of chronic weight-related health conditions. The policy, which is scheduled to take effect in mid-June 2026, reflects a broader move to integrate modern pharmacological treatments into the national … Read more

Bundesverfassungsgericht: Krankenkasse muss Medikament für schwerkranken Mann nicht zahlen – Klage abgewiesen

by

Karlsruhe, Germany – A landmark case concerning access to costly, unapproved medications has concluded at the German Federal Constitutional Court (Bundesverfassungsgericht), leaving a young man with Duchenne muscular dystrophy without the financial support he sought for a treatment no longer authorized for use in the European Union. The court ruled on Wednesday, March 18, 2026, … Read more

The Yo-Yo Effect: Understanding Weight Cycling & How to Break Free

by

The pursuit of weight loss has led many to explore medications like Ozempic and Wegovy, alongside older options‍ such as Orlistat and Fenfluramin.Increasingly, individuals are turning to these drugs to achieve their desired weight. Recent data from a report released in early 2026 indicates that the use⁣ of weight loss medications‍ in Germany has roughly … Read more